700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Introduction: The A & B blood group antigens present on various body tissues are lost following a malignant transformation. Through this study, we have made an attempt to differentiate benign & malignant tumors by the use of this concept. The technique used was Specific Red Cell Adherence (SRCA) based on the principle of Mixed Cell Agglutination on Fine-Needle Aspiration (FNA) samples.
Objective: Our aim was to perform the SRCA test on FNA samples of various human solid tumors and compare them with histopathology (Gold Standard).
Method: A total of 35 FNA samples of swellings suspected to be tumors were collected & the SRCA test was performed on them. The results were compared with histopathology.
Result: The sensitivity of SRCA test was found to be 88.23%; specificity was 72.22%; positive predictive value was 75%; negative predictive value was 86.66% (p<0.05).
Conclusion: SRCA test is an easy & cost-effective technique that can be used for differentiation of benign & malignant tumors on FNA samples.
Specific Red Cell Adherence (SRCA), FNA (Fine-Needle Aspiration), Mixed Cell Agglutination